Please use this identifier to cite or link to this item: https://dipositint.ub.edu/dspace/handle/2445/63891
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBaena Muñoz, Miguel-
dc.contributor.authorSangüesa Puigventós, Gemma-
dc.contributor.authorHutter, Natalia-
dc.contributor.authorSánchez Peñarroya, Rosa M.-
dc.contributor.authorLaguna Egea, Juan Carlos-
dc.contributor.authorAlegret i Jordà, Marta-
dc.contributor.authorRoglans i Ribas, Núria-
dc.date.accessioned2015-03-11T13:20:09Z-
dc.date.available2015-03-11T13:20:09Z-
dc.date.issued2014-
dc.identifier.urihttps://hdl.handle.net/2445/63891-
dc.descriptionPodeu consultar el llibre complet a: http://hdl.handle.net/2445/63704ca
dc.description.abstractGlobal changes in dietary habits in the last decades caused an increase of added sugar consumption all over the world, which has been linked to the increasing prevalence of obesity, dyslipidemia, insulin resistance and cardiovascular disease. Fructose is widely used as a sweetener in the food and beverage industry, either as an integrant of the sucrose molecule or as a component of high fructose corn syrups. The consumption of fructose in beverages is especially dangerous, as the process of energy compensation by reduction in the ingestion of other foods does not work equally well with liquid than solid foods. Besides, fructose is the carbohydrate with the highest ability to induce hypertriglyceridemia, due to a marked increase in lipogenesis compared with glucose. In this review we will discuss some of the most recent studies performed in animal models and in humans to investigate the effects of excessive fructose consumption.ca
dc.format.extent19 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoengca
dc.publisherResearch Signpostca
dc.relation.isformatofReproducció del capítol del llibre publicat a: http://www.trnres.com/ebookcontents.php?id=234-
dc.relation.ispartofRecent Advances in Pharmaceutical Sciences IV, 2014, Research Signpost: Editors: Diego Muñoz Torrero, Manuel Vázquez-Carrera & Joan Estelrich i Latràs. ISBN: 978-81-308-0554-2. Chapter 1, p. 1-19.-
dc.relation.urihttp://hdl.handle.net/2445/63704-
dc.rights(c) Research Signpost, 2014-
dc.sourceLlibres / Capítols de llibre (Farmacologia, Toxicologia i Química Terapèutica)-
dc.subject.classificationFructosacat
dc.subject.classificationTrastorns del metabolismecat
dc.subject.classificationModels animals en la investigació-
dc.subject.otherFructoseeng
dc.subject.otherDisorders of metabolismeng
dc.subject.otherAnimal models in research-
dc.titleFructose effects on human health: Molecular insights from experimental modelsca
dc.typeinfo:eu-repo/semantics/bookPartca
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec287639-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccessca
Appears in Collections:Llibres / Capítols de llibre (Institut de Biomedicina (IBUB))
Llibres / Capítols de llibre (Farmacologia, Toxicologia i Química Terapèutica)

Files in This Item:
File Description SizeFormat 
T_1422616837Munoz-Torrero1.pdf415.66 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.